Aurobac Therapeutics
France · $43.2M raised
- Business Model
- B2B
- Website
- aurobac-tx.com
- Total Funding
- $43.2M
- Last Round
- $43.2M Corporate RoundJul 2022
- Rounds
- 1
About
Anti-Infectives (AMR)
Summary
Aurobac Therapeutics is a Biotech company based in France. It has raised $43.2M in total across 1 round, most recently a $43.2M Corporate Round round in Jul 2022. Investors include Boehringer Ingelheim Venture Fund and Evotec.
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2022
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.